Kumar P - Search Results

1

Multifarious targets beyond microtubules-role of eribulin in cancer therapy.

Seshadri P, Deb B, Kumar P. Seshadri P, et al. Among authors: kumar p. Front Biosci (Schol Ed). 2021 Dec 3;13(2):157-172. doi: 10.52586/S559. Front Biosci (Schol Ed). 2021. PMID: 34879468 Free article. Review.

2

Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma.

Deb B, Puttamallesh VN, Gondkar K, Thiery JP, Gowda H, Kumar P. Deb B, et al. Among authors: kumar p. J Clin Med. 2019 May 17;8(5):703. doi: 10.3390/jcm8050703. J Clin Med. 2019. PMID: 31108958 Free PMC article.

3

Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival.

Balakrishnan A, Koppaka D, Anand A, Deb B, Grenci G, Viasnoff V, Thompson EW, Gowda H, Bhat R, Rangarajan A, Thiery JP, Govind Babu K, Kumar P. Balakrishnan A, et al. Among authors: kumar p. Sci Rep. 2019 May 28;9(1):7933. doi: 10.1038/s41598-019-44404-y. Sci Rep. 2019. PMID: 31138856 Free PMC article.

4

Somatic Mutations Profile of a Young Patient With Metastatic Urothelial Carcinoma Reveals Mutations in Genes Involved in Ion Channels.

Sharma J, Deb B, George IA, Kapil S, Coral K, Kakkar N, Pattanaik S, Mandal AK, Mavuduru RS, Kumar P. Sharma J, et al. Among authors: kumar p. Front Oncol. 2019 May 29;9:435. doi: 10.3389/fonc.2019.00435. eCollection 2019. Front Oncol. 2019. PMID: 31192134 Free PMC article.

5

N-Glycoproteomic Profiling Reveals Alteration In Extracellular Matrix Organization In Non-Type Bladder Carcinoma.

Deb B, Patel K, Sathe G, Kumar P. Deb B, et al. Among authors: kumar p. J Clin Med. 2019 Aug 24;8(9):1303. doi: 10.3390/jcm8091303. J Clin Med. 2019. PMID: 31450586 Free PMC article.

6

Phosphoproteomics Profiling to Identify Altered Signaling Pathways and Kinase-Targeted Cancer Therapies.

Deb B, George IA, Sharma J, Kumar P. Deb B, et al. Among authors: kumar p. Methods Mol Biol. 2020;2051:241-264. doi: 10.1007/978-1-4939-9744-2_10. Methods Mol Biol. 2020. PMID: 31552632

7

Circulating tumor cells as an emerging tool in cancer therapy.

Balakrishnan A, George IA, Kumar P. Balakrishnan A, et al. Among authors: kumar p. Front Biosci (Landmark Ed). 2020 Jan 1;25(4):606-631. doi: 10.2741/4824. Front Biosci (Landmark Ed). 2020. PMID: 31585907 Free article. Review.

8

Epithelial to mesenchymal plasticity: role in cancer progression.

Raja R, Pandey A, Kumar P. Raja R, et al. Among authors: kumar p. Front Biosci (Landmark Ed). 2020 Jan 1;25(5):838-873. doi: 10.2741/4837. Front Biosci (Landmark Ed). 2020. PMID: 31585920 Free article. Review.

9

Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers.

Deb B, Sengupta P, Sambath J, Kumar P. Deb B, et al. Among authors: kumar p. Biomolecules. 2020 Feb 4;10(2):237. doi: 10.3390/biom10020237. Biomolecules. 2020. PMID: 32033228 Free PMC article.

10

The Role of Integrin α₄β₇ Signaling in Human Immunodeficiency Virus-1 Pathogenesis and Viral Entry in Primary CD4⁺ T Cells As Revealed by Comparative Phosphoproteomic Signatures.

Kasarpalkar N, Deb B, Kumar P, Bhor VM. Kasarpalkar N, et al. Among authors: kumar p. OMICS. 2020 Jul;24(7):437-450. doi: 10.1089/omi.2019.0196. Epub 2020 Jun 9. OMICS. 2020. PMID: 32522079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,739 results

Search Page

Filters